PERDOCEO EDUCATION Corp (PRDO): what the price requires

The current priced-in claim for PERDOCEO EDUCATION Corp (PRDO) is temporarily suppressed because the live engine record is unavailable. The dated report remains a snapshot, not a current market read.

Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/PRDO

Headline

FieldValue
TickerPRDO
CompanyPERDOCEO EDUCATION Corp
Current price$36.56/sh
CompositionTuition and fees, net 99% / Other revenue 1%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin needed5.8%
Operating margin today25.4%
Margin compression implied-19.6pp
Multiple paid10x operating income

The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 8.5% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range

ReferenceValue
vs own history-0.30σ
cohort percentile (of 210 peers)15
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.20x5expensive
Earnings0.94x5justifies
Relative0.75x5justifies
Growth0.63x3justifies

Families that justify the price: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.1%); the inversion above states its own rate.

Per-Model Detail (n=18)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$114.030.32xyesFCF base $0.3B, growth 19% (input: historical growth), terminal g 4.0%, WACC 9.1%, 6yr projection
DCF Exit MultipleGrowth$58.060.63xyesExit EV/EBITDA: 6.9x / 8.9x / 10.9x (bear / base = today's held flat / bull), 6yr
Relative ValuationRelative$52.850.69xyesP/E 18x (static sector reference · 2026-04), scenarios: 14.7x / 18.0x / 21.3x (bear / base = reference held flat / bull), EV/EBITDA 12x
Simple DDMGrowth——no—
Two-Stage DDMGrowth——no—
Simple Excess ReturnAsset$29.001.26xyesBV/sh $15.76, ROE (TTM) 17.0%, ke 9.3%
Two-Stage Excess ReturnAsset$38.830.94xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$37.110.99xyesRev $0.9B, growth 19% (input: historical growth; tapered), Terminal P/S: 2.2x / 2.7x / 3.2x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$42.160.87xyesEPS $2.62, growth 16% (input: historical EPS growth), PEG=0.85 (Undervalued)
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings$23.151.58xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.17B × (1−21%) / WACC 9.1% → EPV (no growth)
Residual IncomeAsset$39.050.94xyesBV $15.76 + 5yr PV of (ROE (TTM) 17.0% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$30.481.20xyes√(22.5 × EPS $2.62 × BVPS $15.76) — Graham's conservative floor
EV/EBITDA RelativeRelative$48.450.75xyesEBITDA $0.25B × sector EV/EBITDA 12.0x
FCF YieldEarnings$40.920.89xyesFCF $229.5M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$38.870.94xyesSBC-adj FCF $0.22B (FCF $0.23B − SBC $0.01B) capitalized at Kₑ
Ben Graham FormulaEarnings$84.540.43xyesEPS $2.62 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$9.753.75xyesBV $15.76 × (ROIC 5.6% / WACC 9.1%)
P/Sales SectorRelative$33.691.09xyesRevenue $0.85B × sector P/S 2.5x
PEG Fair ValueRelative$63.240.58xyesEPS $2.62 × (PEG 1.5 × growth 16.1% (input: historical EPS growth)) → PE 24.1x
Earnings YieldEarnings$28.321.29xyesEPS $2.62 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Net cash$668.9m
Net debt / NOPAT (after-tax)-3.90x (net cash)
Net debt / operating income (pre-tax)-3.08x (net cash)
Interest coverage33.9x
Share count CAGR (buyback)-2.3%
Burning cashno

Bullet Takeaways

Bull Case

What a quick screen misses about Perdoceo is the balance sheet hiding behind the operations. This is a for-profit education company that the market files under regulatory risk, yet it runs a 24% operating margin and holds about $669 million of net cash with interest coverage above 30 times. A meaningful slice of the market value is just the cash, which means the operating business is being valued at a very low multiple of its earnings. For a company with no debt and a recurring tuition stream, that is an unusual amount of downside protection sitting in plain sight.

The operating performance has been quietly strong. First-quarter 2026 revenue rose 4.1% to $221.7 million, operating income jumped 22% to $63.1 million, and adjusted EPS grew to $0.90 from $0.70, with total enrollment up 1.1% to 48,740. Management guided full-year adjusted EPS to $3.05 to $3.16, up from $2.61 in 2025, and operating income of $217 million to $226 million. The portfolio is broadening, with growth at CTU and the health-sciences unit offsetting a temporary dip at AIU that management expects to return to growth. This is a business executing on retention and disciplined marketing, not one in decline.

The capital return turns the cash and the cheap multiple into a shareholder-friendly story. Perdoceo authorized a new $100 million buyback through mid-2027, having already retired shares under the prior program, shrinking the count at roughly 2% to 3% a year, and it pays a $0.15 quarterly dividend. The bull case is simple: a debt-free, cash-rich, high-margin business buying back its own undervalued stock while the market applies a permanent regulatory discount.

Bear Case

The methods that disagree the least with the cash still flag the same structural problem, and the conservative read is the more honest one: this is a business whose revenue depends almost entirely on federal student aid, and that dependence caps what the market will pay for it no matter how cheap it looks. The filing is explicit that loan-program changes could hurt demand, noting it "cannot currently predict the extent to which reduced federal loan availability may influence prospective student demand" and pointing to "Gainful Employment" and other federal regulatory standards (FY2025 10-K). It adds that it "cannot predict the extent to which these loan program changes, individually or in combination with other regulatory developments, will affect student behavior or our institutions' enrollment trends" (FY2025 10-K). A single adverse rule on aid eligibility, gainful employment, or the 90/10 revenue test can impair the entire business, and that is why the low multiple persists.

The enrollment durability is the second concern. For-profit online education has a history of boom-and-bust enrollment tied to the economy and to regulatory cycles, and the AIU dip in the quarter, even if temporary, shows the model is not immune to soft patches. The growth is modest, around 1% enrollment and low-single-digit revenue, so this is not a compounder; it is a cash-generative but slow-growth business in a politically exposed industry.

The reputational and reinvestment risk rounds it out. For-profit education carries a persistent reputational discount that can affect student demand and political treatment regardless of academic outcomes, and the large cash pile invites questions about reinvestment, with the risk that capital goes to acquisitions in the same exposed industry. The price is cheap precisely because the market doubts the durability of the earnings, and if a regulatory change or an enrollment downturn validates that doubt, the cash cushion softens the blow but does not prevent the operating value from falling.

Valuation

The growth-DCF and peer methods are the most generous, in the $50s, while the earnings-power method sits closer to the price. A reasonable-growth re-pricing puts the base near $62, well above the quote. The unusually wide gap between price and methods is what produces the cheap screen, and a large portion of the value is the net cash.

Inverting the price into the assumption it embeds, the market is paying only about 9 times company-wide operating income, a multiple so low the price sits below what even a 5% per year operating-profit decline would warrant. That is a bound, not a solved growth rate: the price is effectively assuming the business shrinks, which is the market pricing in regulatory and enrollment risk rather than a forecast of decline. Against the company's own history the implied pace is within range.

The honest conclusion is that the disagreement between the deep-value methods and the low multiple is entirely the regulatory discount. If federal aid policy stays workable and enrollment holds, the stock is materially undervalued and the buyback compounds that gap. If a regulatory change impairs the model, the low multiple is closer to fair. The net cash and high margin provide a real floor, but the upside requires the market to grant the earnings durability it currently withholds. This is a cash-rich value name where the central variable is policy, not operations.

Catalysts

The near-term catalysts are enrollment trends and capital return. First-quarter 2026 revenue rose 4.1% to $221.7 million, operating income grew 22% to $63.1 million, adjusted EPS reached $0.90, and total enrollment rose 1.1% to 48,740, with management expecting the AIU unit to return to growth in the second quarter. Full-year adjusted EPS guidance is $3.05 to $3.16 and operating income $217 million to $226 million. The pace of enrollment recovery across the portfolio and the EPS trajectory are the operating signals.

Capital allocation is the second driver and the clearest near-term lever. The board authorized a new $100 million buyback through mid-2027, replacing a prior program under which Perdoceo had already repurchased about 2.5 million shares for roughly $74.8 million, and it pays a $0.15 quarterly dividend. With a large net-cash balance, continued repurchases at a low multiple are directly accretive, and any move to deploy the cash, through a larger buyback, a special dividend, or an acquisition, would be a catalyst.

The dominant risk to monitor is regulatory: changes to federal student loan availability, gainful-employment rules, or the 90/10 revenue test could materially affect enrollment and revenue, since the business depends on Title IV aid. Analyst coverage is thin but constructive, with a Buy lean and a recent Barrington target increase to $44, well above the current price, reflecting the deep-value setup against the regulatory overhang.

Sources:

Peer Cohorts (Per Segment, With Filing Citations)

CTU (reported)

AIUS (reported)

USAHS (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive PRDO report on boothcheck